Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic bilastine 20 mg orodispersible tablets vs BILAXTEN 20 MG ODT under fasting in healthy Thai volunteers
TCTR20260620003Phase 2Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bilastine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by International Bio Service. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bilastine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20260620003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260620003.